Navigation Links
FDA Approves First Generic Version of Cholesterol-Lowering Drug Lipitor
Date:11/30/2011

SILVER SPRING, Md., Nov. 30, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first generic version of the cholesterol-lowering drug Lipitor (atorvastatin calcium tablets).

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Ranbaxy Laboratories Ltd. has gained approval to make generic atorvastatin calcium tablets in 10 milligram, 20 mg, 40 mg, and 80 mg strengths. The drug will be manufactured by Ohm Laboratories in New Brunswick, N.J.

People who have high blood cholesterol levels have a greater chance of getting heart disease. By itself, the condition usually has no signs or symptoms. Thus, many people do not know that their cholesterol levels are too high.

"This medication is widely used by people who must manage their high cholesterol over time, so it is important to have affordable treatment options," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. "We are working very hard to get generic drugs to people as soon as the law will allow."

Not all cholesterol in your blood is bad. There are three kinds of blood cholesterol that you should know about: high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides. HDL (good cholesterol) helps keep cholesterol from building up in the arteries. LDL (bad cholesterol) is the main source of cholesterol buildup and blockage in the arteries, which can prevent proper blood flow to your heart and lead to a heart attack. Triglycerides can lead to hardening of the arteries.

Atorvastatin is a statin, a type of drug that lowers cholesterol in the body by blocking an enzyme in the liver. Atorvastatin is used along with a low-fat diet to lower the LDL cholesterol and triglycerides in the blood. The drug can raise HDL cholesterol as well. Atorvastatin lowers the risk for heart attack, stroke, certain types of heart s
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves First Insomnia Drug for Middle-of-the-Night Waking Followed By Difficulty Returning to Sleep
2. FDA Approves Eylea for Eye Disorder in Older People
3. FDA Approves First Supplemental Test for Chagas Disease
4. FDA Approves Erwinaze to Treat a Form of Leukemia
5. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
6. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
7. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
8. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
9. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
10. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
11. FDA Approves Onfi To Treat Severe Type of Seizures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
(Date:7/2/2015)... de julio de 2015 BGI anunció hoy ... alto rendimiento en Hong Kong ... Pathologists (CAP). La instalación de BGI en Hong ... de próxima generación que recibe la certificación CAP en ... estándar en prácticas de laboratorio clínico. Junto con el ...
(Date:7/2/2015)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), a ... and tissue hypothermic storage and cryopreservation freeze ... chain management app for smart shippers ("BioLife" ... has included BioLife in its annual list of the ... state for 2015. Now in its ...
Breaking Medicine Technology:Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4BGI recibe la acreditación del College of American Pathologists (CAP) 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3
... 4Q07/1Q08, DALLAS, Aug. 20 Access Pharmaceuticals, ... on the clinical,development plan of ProLindac, its novel ... human clinical trials to be initiated in,late 2007/ ... ovarian,cancer patients, designed to optimize single agent dosing ...
... in the journal Blood found 92 percent reduction in ... ... Patients with a rare,blood disorder called PNH experienced a ... following treatment,with Soliris(TM) (eculizumab), according to an analysis of clinical ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 2PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 3PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 4PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 5PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 6PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 7PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials 8
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ” was ... and coolest technology products available to consumers. Amanda Forstrom, a technology expert and special ... are great for documenting memories. , Almost every smartphone has an incredibly powerful camera ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Every year, ... 24-Hour Train-a-Thon where they provide members of the Red Deer community with free fitness ... day of fitness training, games, food, events and entertainment raised thousands of charity dollars ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to ... the first sweetFrog store located in Mississippi. The premium frozen yogurt chain was listed ... The store, located at 104 Railroad Avenue, New Albany, MS 38652, will have a ...
(Date:7/2/2015)... ... , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its ... in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... which opened July 1 at Duke’s Travel Plaza, is located at:, 30176 Hwy 64, ...
Breaking Medicine News(10 mins):Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... that the established normal ranges for evaluating electrocardiograms for ... recommendation comes in a study published today in the ... from more than 700 patients 80 or older, the ... points) for measuring all three ECG intervals -- PR, ...
... Study found those who gained weight rapidly, were ... , , FRIDAY, March 14 (HealthDay News) -- Surgery ... with sleep-disordered breathing, say researchers at Cincinnati Children,s ... first line of treatment for sleep-disordered breathing (SDB) ...
... Edwards Lifesciences,Corporation (NYSE: EW ), a world ... is scheduled to participate in the,Citi 5th Annual Small ... Vegas on Wednesday, March 19, 2008., Donald E. ... scheduled to speak to conference attendees at 1:05 p.m.,PT. ...
... Bernadette Toomey, President and Chief Executive Officer,American Lung ... The American Lung,Association salutes the new U.S. ... the air pollution produced by locomotive and,marine diesel ... help to help clean up dangerous ozone and ...
... SPRINGS, Colo., March 14 Secondhand,smoke in the ... as early as,the toddler years, researchers reported at ... Disease Epidemiology and,Prevention., It has long been ... are initiated and progress silently during childhood. Now,researchers ...
... 2008) − Transcendental Meditation is an effective treatment ... benefit of bypassing possible side effects and hazards ... conducted at the University of Kentucky. The study ... Journal of Hypertension. , The meta-analysis evaluated nine ...
Cached Medicine News:Health News:Mayo researchers say ECG standards should be revised for elderly 2Health News:Surgery Only Works for Some Kids with Sleep Apnea 2Health News:Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference 2Health News:Locomotive and Marine Diesel Engines Clean Up Will Save Lives 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 2Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 3Health News:Toddlers Affected Most by Secondhand Smoke Exposure at Home 4
Bone removing chisel for decortication of lumbar vertebral bodies....
Rasp with down cutting pattern....
9 inch sharp bone hook with grip handle....
Lewin Bone Forceps, serrated and slightly curved. To hold, stabilize, rotate, reduce and,compress bone....
Medicine Products: